Navigation Links
Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
Date:5/18/2012

ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Lansoprazole capsules (15 mg). Shipments of product to customers have already begun. 

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

This new product for the U.S. store brand market is bioequivalent to Novartis' Prevacid® 24HR capsules (15 mg) and is indicated for the treatment of frequent heartburn, which occurs two or more days in a week. Sales for Prevacid OTC were approximately $220 million.

Perrigo's Chairman, President and CEO Joseph C. Papa stated, "This is another example of Perrigo's continued leadership and commitment to bring key new products to the store brand OTC market. Perrigo continues to be focused on our mission of making quality healthcare more affordable for consumers. We are pleased to be in a position to bring this important new product to market – for our retail and wholesale customers' store brand product portfolios and to U.S. consumers, who will realize considerable savings now that they can purchase a high quality, value priced alternative to the national brand."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).'/>"/>

SOURCE Perrigo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... DIEGO , May 26, 2015 ... developing targeted therapeutic devices to address infectious diseases ... Joyce , Chief Executive Officer, will present at ... Thursday, May 28th.  Details of Aethlon Medical,s presentation ... Investor Conference Date: , Thursday, May 28, 2015Time: ...
(Date:5/26/2015)... , May 26, 2015 ViiV ... Inc. (CHAI) announced today that Aurobindo Pharma has submitted ... for Tentative Approval, to the Food and Drug Administration ... first ANDA for a generic version of dolutegravir, less ... for sale in the United States ...
(Date:5/26/2015)... Mass. , May 26, 2015  Respiratory ... 62 nd Annual Meeting of the Japanese ... of monitoring patient respiration in hospitals miss critical ... risks to patients. The findings conclude that respiratory ... Respiratory Motion, Inc. more consistently protects patients than ...
Breaking Medicine Technology:Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... 2010 HeartWare International, Inc. (Nasdaq: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to make an investor presentation at ... December 7, 2010 at 9:00 a.m. Pacific Time (noon, ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... the UK has completed review of the Clinical Trial Application ... 673 for genetically-defined cancers.  The company expects to initiate a ... "BMN 673 has been proven to be highly active ...
Cached Medicine Technology:HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 3
(Date:5/26/2015)... 26, 2015 In God’s Unstoppable Favor, ... as she writes an unforgettable story of how God ... life. The first black student to desegregate Evangeline Parish ... by some students, treated harshly by a few teachers, ... personal phone conversation with Dr. Martin Luther King, Jr. ...
(Date:5/26/2015)... 26, 2015 Dermatologic surgeons performed nearly ... according to survey results released today by the American ... cancer treatments and several cosmetic categories, 2014 totals were ... steady overall compared to 2013 figures. , For ... ranked as the most-performed procedure (3.08 million) by ASDS ...
(Date:5/26/2015)... York (PRWEB) May 26, 2015 The ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who were ... the litigation’s June 11th Science Day. According to an ... of Louisiana, on May 21st, topics to be addressed ... drug, the use of blood test based testing with ...
(Date:5/26/2015)... Rochester, MN (PRWEB) May 26, 2015 ... years of debilitating nosebleeds and fainting spells, four of ... even leading to cardiac arrest. , Though she ... transfusion, she continues to dedicate her time to increasing ... mission. , “Had there been awareness, we could have ...
(Date:5/26/2015)... May 26, 2015 Last week, ... Mexico patients with MRI, Ultrasound, and CT services—was ... American College of Radiology. The center is now ... , In order to be eligible for ... of qualifications including personnel qualifications, adequacy of facility ...
Breaking Medicine News(10 mins):Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4Health News:Rochester Woman Brings Awareness to Genetic Disease 2
... it as been found in a study that drinking coffee may ... consumption should be moderate. Its moderate consumption every day may lower ... studies in US had linked drinking more than two cups of ... chronic liver disease. ,This new study by Harvard School ...
... Australian scientists are of the opinion that older adults ... heart disease. // ,The researchers at the ... a high risk than those without asthma to suffer ... and cancer,The study’s lead author Dr. Robert Adams ...
... government is facing accusation from the Victorian Opposition for ... ,Reports are rife that almost one in ... of being discharged from the hospital, necessitating a re-admission. ... Government about mental health shortfalls, during the previous year. ...
... the socioeconomic status of an individual that determines the ... published in the March 15, 2006 issue of CANCER, ... ,The study found that education, community poverty, and income ... outcomes as did age, disease stage, and treatment method. ...
... public display of their affection here on Valentine's Day would ... some young lovers. ,Youngsters have got over the initial ... lovers by the Akhil Bharatiya Vidhyarthi Parishad (ABVP), the Vishwa ... move is now being welcomed by courting couples, who are ...
... their telephonic conversations to a minimal level owing to the ... federal bureau for radiation protection (BfS) in Salzgitter says people ... station in an area of their home where they do ... is a good example. ,The cordless telephones, which commonly ...
Cached Medicine News:
... model in the PM series is ... required for routine brightfield observation, both ... photography. Remarkably economical in,price, it offers ... mechanisms which meet the needs of ...
... digital FireWire camera system for high resolution ... provides images of the highest color fidelity, ... users can expect perfect images due to ... cooling and innovative readout modes. The Leica ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
... Stains for Geometric Data Hemastainer. ... Stains are quality control tested ... ensure proper staining and absence ... applications for a minimum of ...
Medicine Products: